Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Guidewire Software Inc.'s CEO, Michael George Rosenbaum, sold 1,200 shares on March 9, 2026, under a pre-established 10b5-1 plan for $199,608. The transaction comes as the stock trades below its sale price and after the company reported better-than-expected fiscal second-quarter results and raised its fiscal 2026 outlook. Analysts reacted with mixe…
Karen L. Sedgwick, Sempra's executive vice president and chief financial officer, sold 4,872 shares of common stock on March 9, 2026 under a pre-arranged 10b5-1 trading plan, generating $451,041. The transactions occurred in three tranches at prices between $91.36 and $93.52. The sale comes as Sempra stock trades near $93.51 amid mixed financial si…
A director of Ramaco Resources, Inc. executed a block sale of Class A common stock on March 5, 2026, disposing of 20,115 shares for roughly $305,327. The transactions were carried out through three Yorktown-affiliated entities and reflect a mix of indirect and direct holdings that the director continues to retain. The sales occurred as the stock tr…
Shannon Lei Okinaka, a member of Universal Technical Institute's board, sold 10,000 shares of the company's common stock on March 6, 2026, for roughly $347,414. The stock is trading around $35.17 after notable gains year-to-date and over the past six months. Universal Technical Institute reported mixed first-quarter fiscal 2026 results, with an EPS…
Cerus CORP Chief Financial Officer Kevin Dennis Green sold 83,021 shares across two transactions on March 5 and March 6, 2026, realizing roughly $169,646. The trades coincide with recent stock movement and the company’s reported fourth-quarter 2025 results showing revenue growth to $233.8 million and EPS of -$0.01.
Saba Capital Management, L.P., identified as a 10% holder of BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), sold 147,371 shares across two trades on March 5 and March 6, 2026, for a combined $2,175,165. After the transactions the firm indirectly holds 22,723,109 shares. The move comes while ECAT trades near $14.57, carries a reported 2…
GRAIL CFO Aaron Freidin sold 3,147 shares of GRAIL, Inc. across two dates in March 2026, netting $154,061 in broker-executed sell-to-cover transactions intended to satisfy tax withholding obligations. The trades, filed on Form 4, occurred at prices between $46.74 and $53.01. Separately, GRAIL reported fourth-quarter and full-year 2025 results that …
Joshua J. Ofman, President of GRAIL, Inc. (NASDAQ: GRAL), reported the sale of 3,827 shares of common stock for proceeds of $177,227 in a Form 4 filing with the SEC. The transactions occurred between March 5 and March 9, 2026, and were identified in the filing as automatic sell-to-cover trades to satisfy withholding taxes tied to award vesting and …
Grail Chief Executive Officer Robert P. Ragusa sold $409,245 worth of company stock in several transactions earlier this month, filings show. The sales were executed to satisfy withholding tax obligations tied to award vesting and share delivery. The equity moves come amid mixed operational results for the company, including growth in Galleri testi…
Cerus Corp's Chief Medical Officer, Richard J. Benjamin, sold 125,964 shares of company stock between March 5 and March 9, 2026, for about $202,334, while acquiring 55,220 shares at no cost on March 5. After the transactions, Benjamin directly holds 879,101 shares. The insider activity coincides with a recent 9.4% one-week share decline and follows…
Cerus Corporation's chief legal officer, Jensen Chrystal, sold 30,845 shares of common stock on March 6, 2026, for $2.0055 per share, totaling $61,859, according to a Form 4 filing. The sale lowered her direct stake in the company to 1,059,139 shares. The transaction followed an acquisition of 55,220 shares on March 5, 2026, recorded at $0.0. The s…
Cerus Corp Chief Operating Officer Vivek K. Jayaraman sold 34,094 shares on March 6, 2026 to fulfill statutory tax withholding and brokerage fees tied to restricted stock unit vesting, netting $68,375 at $2.0055 per share. The transactions followed a no-cost receipt of 80,320 shares on March 5, 2026. Cerus reported $233.8 million in revenue for Q4 …
William Mariner Greenman, President and CEO of Cerus Corp (CERS), completed an automatic sale of 78,187 shares on March 6, 2026 to satisfy tax withholding and broker fees tied to restricted stock unit vesting. The sale, at $2.0055 per share for $156,804, followed a no-cost issuance of 193,270 shares on March 5, 2026. After these filings, Greenman d…
iHeartMedia Chairman and CEO Robert W. Pittman bought 16,349 shares of Class A common stock on March 9, 2026, in a transaction valued at $48,525. The purchase was disclosed on a Form 4 filing with the SEC. The move comes after the company posted Q4 2025 revenue that beat estimates, driven by podcast growth and cost savings, even as net debt remains…
Douglas M. Pasquale, a member of Dine Brands Global's board, executed a purchase of 500 shares on March 9, 2026, for $15,000. The transaction follows a separate conversion of restricted stock units into 4,946.607 shares on March 6, 2026. These insider moves occur amid a fiscal fourth-quarter report that missed some consensus metrics while the compa…
Adaptive Biotechnologies Chief People Officer Lo Francis sold 38,074 shares on March 5, 2026, for $15.09 per share, generating $574,536 in proceeds to cover tax withholding tied to RSU vesting. The transaction leaves Francis with 321,967 directly held shares and an indirect holding of 2,500 shares through spouse You Jin Lee. Separately, Adeptus Bio…
Tosha Perkins, Chief Administrative Officer of Archer Aviation Inc. (ACHR), sold 54,786 Class A shares on March 5, 2026, generating $353,972 to satisfy tax obligations from restricted stock unit vesting. The sale occurred across multiple trades at prices between $6.315 and $6.775, with a weighted average of $6.461. Perkins retains direct ownership …
Pinterest director Rajaram Gokul sold 1,050 Class A shares on March 6, 2026, under a pre-established 10b5-1 plan, realizing $21,000 at $20.00 per share. The transaction leaves him with 29,550 directly held shares and an indirect holding of 3,957 shares through a family trust. The sale comes as the company announces a $1 billion convertible note fro…
Enrico Digirolomo, a director at Coherent Corp (NASDAQ: COHR), sold 3,911 shares of common stock on March 6, 2026, at $241.50 per share for a total of $944,506. After the sale, he directly holds 17,446 shares. The same day he donated 1,847 shares to a donor advised fund valued at $0 and exercised options to buy 1,005 and 2,906 shares. The stock has…
EchoStar CORP's Chief Legal Officer Dean Manson reported the sale of 19,031 Class A shares on March 5, 2026, for about $2.18 million, according to an SEC Form 4. The transaction occurred the same day Manson exercised options to acquire 21,631 shares at $14.04 per share. The stock has risen 291% over the past year but declined 7.4% in the prior week…
Item Second Irr. Trust FBO Kyle R. Westphal, identified as a ten percent owner of Vertex, Inc. (NASDAQ: VERX), sold 10,000 shares of Class A Common Stock on March 9, 2026, for $150,477 at a weighted average price of $15.0477. The transaction reduced a holding that still stands at 1,221,100 shares. The sale occurs as VERX trades at $14.94, down 54% …
Broadridge Financial Solutions Chief Executive Timothy C. Gokey bought 5,300 shares on March 6, 2026, in a transaction valued at $1,030,794. The move coincides with the company’s announced agreement to acquire CQG and a mix of analyst reactions that include reiterated and upgraded Buy ratings alongside trimmed price targets.
Jennifer Baldock, Chief Admin & Dev Officer of Surgery Partners, sold 10,082 shares on March 6, 2026 to meet tax obligations tied to a restricted stock vesting, while receiving 106,207 restricted shares the prior day. The company has recently reported results and guidance that prompted analyst price-target reductions and completed a sizable acquisi…
Surgery Partners Chief Executive Officer Jason Eric Evans sold 11,462 shares on March 6, 2026, for $13.79 per share, generating proceeds of $158,060 to cover tax liabilities tied to restricted stock vesting. The transactions followed a grant of 278,106 restricted shares on March 5, 2026, and leave Evans with 940,786 shares outstanding. The stock is…
Surgery Partners CFO David T. Doherty disposed of 14,574 shares on March 6, 2026, to meet tax withholding tied to newly vested restricted stock. The sale came as the company's shares trade close to a 52-week low, after a recent weekly decline. Doherty still holds 88,803 shares after the transaction. Separately, the company expanded its ambulatory f…
